Literature DB >> 25506517

Reduced locomotor activity correlates with increased severity of arthritis in a mouse model of antibody-induced arthritis.

Narendiran Rajasekaran1, Ricky Tran1, Conrado Pascual2, Xinmin Xie2, Elizabeth D Mellins1.   

Abstract

INTRODUCTION: Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovial hyperplasia and progressive cartilage and bone destruction that leads to a substantial loss of general functions and/or a decline in physical activities such as walking speed in humans. The K/BxN serum transfer arthritis in mice shares many immunological and pathological features with human RA. Very few studies are available in mice that investigate the changes in physical activity in relation to arthritis development. In this study we investigate the effect of arthritis on the locomotor activity of mice during K/BxN sera transfer arthritis.
METHODS: Arthritis was induced in Balb/c mice by injecting intraperitoneally with 200ul of K/BxN sera; Balb/c mice injected with phosphate buffered saline (PBS) served as control. Progress of arthritis was estimated by daily measurements of joint thickness. Each mouse's locomotor activity (travel distance and travel time) was assessed every day for duration of 20 minute period using the SmartCage™ platform. Data were analyzed using the SmartCage™ analysis software (CageScore™).
RESULTS: Arthritic Balb/c mice showed a reduction in distance covered and travel speed when compared to arthritis-free, control Balb/c mice. Maximum decline in locomotor activity was observed during the peak period of the disease and correlated to the increase in joint thickness in the arthritic mice.
CONCLUSION: This report demonstrates that measuring locomotor activity of mice during progression of K/BxN sera-induced arthritis using the SmartCage™ platform offers a quantitative method to assess physical activity in mice during arthritis.

Entities:  

Keywords:  Arthritis; K/BxN; Locomotion; Serum transfer

Year:  2014        PMID: 25506517      PMCID: PMC4264968          DOI: 10.4236/ojra.2014.41010

Source DB:  PubMed          Journal:  Open J Rheumatol Autoimmune Dis        ISSN: 2163-9914


  34 in total

1.  Validity of reported energy expenditure and reported intake of energy, protein, sodium and potassium in rheumatoid arthritis patients in a dietary intervention study.

Authors:  L Hagfors; K Westerterp; L Sköldstam; G Johansson
Journal:  Eur J Clin Nutr       Date:  2005-02       Impact factor: 4.016

Review 2.  Review of dietary therapy for rheumatoid arthritis.

Authors:  L G Darlington; N W Ramsey
Journal:  Compr Ther       Date:  1994

3.  Characterization of the acute and persistent pain state present in K/BxN serum transfer arthritis.

Authors:  Christina A Christianson; Maripat Corr; Gary S Firestein; Anahita Mobargha; Tony L Yaksh; Camilla I Svensson
Journal:  Pain       Date:  2010-08-23       Impact factor: 6.961

Review 4.  Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders.

Authors:  L G Darlington; T W Stone
Journal:  Br J Nutr       Date:  2001-03       Impact factor: 3.718

5.  Foot and ankle joint kinematics in rheumatoid arthritis cannot only be explained by alteration in walking speed.

Authors:  R Dubbeldam; A V Nene; J H Buurke; C G M Groothuis-Oudshoorn; H Baan; K W Drossaers-Bakker; M A F J van de Laar; H Hermens
Journal:  Gait Posture       Date:  2011-02-05       Impact factor: 2.840

6.  Rodent motor and neuropsychological behaviour measured in home cages using the integrated modular platform SmartCage™.

Authors:  Taline V Khroyan; Jingxi Zhang; Liya Yang; Bende Zou; James Xie; Conrado Pascual; Adam Malik; Julian Xie; Nurulain T Zaveri; Jacqueline Vazquez; Willma Polgar; Lawrence Toll; Jidong Fang; Xinmin Xie
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-07       Impact factor: 2.557

7.  Dynamic visualization of a joint-specific autoimmune response through positron emission tomography.

Authors:  Brian T Wipke; Zheng Wang; Joonyoung Kim; Timothy J McCarthy; Paul M Allen
Journal:  Nat Immunol       Date:  2002-03-18       Impact factor: 25.606

8.  Talonavicular joint abnormalities and walking ability of patients with rheumatoid arthritis.

Authors:  Noriyoshi Miyamoto; Masuo Senda; Masanori Hamada; Yoshimi Katayama; Atsushi Kinosita; Kensuke Uchida; Hajime Inoue
Journal:  Acta Med Okayama       Date:  2004-04       Impact factor: 0.892

9.  The posterior tibial tendon and the tarsal sinus in rheumatoid flat foot: magnetic resonance imaging of 40 feet.

Authors:  E T Jernberg; P Simkin; M Kravette; P Lowe; G Gardner
Journal:  J Rheumatol       Date:  1999-02       Impact factor: 4.666

10.  Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes.

Authors:  Brian T Wipke; Zheng Wang; Wouter Nagengast; David E Reichert; Paul M Allen
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

View more
  4 in total

1.  Direct activation of G-protein-gated inward rectifying K+ channels promotes nonrapid eye movement sleep.

Authors:  Bende Zou; William S Cao; Zhiwei Guan; Kui Xiao; Conrado Pascual; Julian Xie; Jingxi Zhang; James Xie; Frank Kayser; Craig W Lindsley; C David Weaver; Jidong Fang; Xinmin Simon Xie
Journal:  Sleep       Date:  2019-03-01       Impact factor: 5.849

Review 2.  Animal models of rheumatoid pain: experimental systems and insights.

Authors:  Bradford D Fischer; Adeshina Adeyemo; Michael E O'Leary; Andrea Bottaro
Journal:  Arthritis Res Ther       Date:  2017-06-30       Impact factor: 5.156

3.  Intra-iliac bone marrow injection as a novel alternative to intra-tibial inoculation in rat model.

Authors:  Julia Steitz; Mamdouh Afify; Marwa S Khattab; Huda O AbuBakr; Kassem G El Iraqi; Naglaa A AbdElKader; Mervat M Kamel; Khaled Hamed Salem
Journal:  Stem Cell Res Ther       Date:  2021-06-10       Impact factor: 6.832

4.  In Vivo Assessment of Phage and Linezolid Based Implant Coatings for Treatment of Methicillin Resistant S. aureus (MRSA) Mediated Orthopaedic Device Related Infections.

Authors:  Sandeep Kaur; Kusum Harjai; Sanjay Chhibber
Journal:  PLoS One       Date:  2016-06-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.